Efficacy of a Novel Intra-Articular Administration of Platelet-Rich Plasma One-Week Prior to Hyaluronic Acid versus Platelet-Rich Plasma Alone in Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Controlled Trial
- PMID: 35683635
- PMCID: PMC9181501
- DOI: 10.3390/jcm11113241
Efficacy of a Novel Intra-Articular Administration of Platelet-Rich Plasma One-Week Prior to Hyaluronic Acid versus Platelet-Rich Plasma Alone in Knee Osteoarthritis: A Prospective, Randomized, Double-Blind, Controlled Trial
Abstract
Recent studies have suggested that the combined injection of platelet-rich plasma (PRP) and hyaluronic acid (HA) may have additive benefits for knee osteoarthritis over PRP alone, but there is insufficient evidence to support this combined injection. Moreover, the simultaneous injection of PRP and HA may offset the combined effect. Hence, the aim of this prospective, randomized, double-blind study was to assess their combined efficacy with a novel injection protocol. Forty-six study subjects with unilateral knee osteoarthritis were randomized to receive either a single-dose injection of HA (intervention group) or normal saline (control group) 1 week after a single-dose injection of leukocyte-poor PRP. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and static balance and the risk of falls measured by Biodex Balance System were, respectively, the primary and secondary outcome measures. Evaluations were performed at baseline, 1 month, 3 months, 6 months, and 12 months post-injection. The intervention group exhibited significant declines in WOMAC pain, stiffness, and total scores, as well as static balance, compared to the control group (p < 0.05). These randomized double-blind control trials, with novel protocol of intra-articular injection of PRP 1-week prior to HA, provide greater symptom relief and improve static balance compared to PRP alone in patients with knee osteoarthritis.
Keywords: balance; hyaluronic acid; knee; osteoarthritis; platelet-rich plasma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis.Am J Sports Med. 2017 Feb;45(2):339-346. doi: 10.1177/0363546516665809. Epub 2016 Oct 21. Am J Sports Med. 2017. PMID: 28146403 Clinical Trial.
-
Comparison of the short-term results of single-dose intra-articular peptide with hyaluronic acid and platelet-rich plasma injections in knee osteoarthritis: a randomized study.Clin Rheumatol. 2020 Oct;39(10):3057-3064. doi: 10.1007/s10067-020-05121-4. Epub 2020 May 1. Clin Rheumatol. 2020. PMID: 32358661 Free PMC article. Clinical Trial.
-
Comparing the Efficacy of Intra-Articular Single Platelet-Rich Plasma(PRP) versus Novel Crosslinked Hyaluronic Acid for Early-Stage Knee Osteoarthritis: A Prospective, Double-Blind, Randomized Controlled Trial.Medicina (Kaunas). 2022 Aug 1;58(8):1028. doi: 10.3390/medicina58081028. Medicina (Kaunas). 2022. PMID: 36013495 Free PMC article. Clinical Trial.
-
Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Am J Sports Med. 2021 Jan;49(1):249-260. doi: 10.1177/0363546520909397. Epub 2020 Apr 17. Am J Sports Med. 2021. PMID: 32302218
-
Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis.BMC Musculoskelet Disord. 2020 Apr 11;21(1):224. doi: 10.1186/s12891-020-03262-w. BMC Musculoskelet Disord. 2020. PMID: 32278352 Free PMC article.
Cited by
-
Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial.Front Bioeng Biotechnol. 2022 Nov 25;10:1062371. doi: 10.3389/fbioe.2022.1062371. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36507262 Free PMC article.
-
Platelet-rich plasma intra-articular knee injections from open preparation techniques do not pose a higher risk of joint infection: A systematic review of 91 randomized controlled trials and 5914 injections.J Exp Orthop. 2024 Sep 23;11(3):e70002. doi: 10.1002/jeo2.70002. eCollection 2024 Jul. J Exp Orthop. 2024. PMID: 39318712 Free PMC article. Review.
-
Platelet-Rich Plasma One Week Prior to Hyaluronic Acid vs. Platelet-Rich Plasma Alone for the Treatment of Knee Osteoarthritis.Biomedicines. 2022 Nov 4;10(11):2805. doi: 10.3390/biomedicines10112805. Biomedicines. 2022. PMID: 36359325 Free PMC article.
-
Randomized Controlled Trials for Platelet-Rich Plasma Use in Knee Osteoarthritis Rarely Report Key Sociodemographic Patient Variables: A Scoping Review.Arthrosc Sports Med Rehabil. 2024 Aug 23;6(6):100988. doi: 10.1016/j.asmr.2024.100988. eCollection 2024 Dec. Arthrosc Sports Med Rehabil. 2024. PMID: 39776510 Free PMC article.
-
The efficacy and safety of intra-articular platelet-rich plasma versus sodium hyaluronate for the treatment of osteoarthritis: Meta-analysis.PLoS One. 2025 Mar 21;20(3):e0314878. doi: 10.1371/journal.pone.0314878. eCollection 2025. PLoS One. 2025. PMID: 40117278 Free PMC article.
References
-
- Ahmad H.S., Farrag S.E., Okasha A.E., Kadry A.O., Ata T.B., Monir A.A., Shady I. Clinical outcomes are associated with changes in ultrasonographic structural appearance after platelet-rich plasma treatment for knee osteoarthritis. Int. J. Rheum. Dis. 2018;21:960–966. doi: 10.1111/1756-185X.13315. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials